REST EZ Inc. (ticker: RTEZ) is an OTC-listed pharma company. DredgeCap's structured extraction of RTEZ's SEC filings surfaces 4 active risk signals, including 3 late-filing signals, and 1 auditor-change signal. RTEZ reported $0 in revenue and $0 for the period ending 2025-12-31, with operating cash flow of $0. Cash and equivalents stood at $300. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
RTEZ Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for REST EZ Inc. (RTEZ) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.